Natural History Study in Patients With LGMDR5/2c

计划入组 50 人 · 首次发布于 2024 年 1 月 18 日

Trial of MRSA Polymerase Chain Reaction for Pneumonia

计划入组 45 人 · 首次发布于 2016 年 1 月 21 日

Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)

计划入组 60 人 · 首次发布于 2011 年 9 月 22 日

Interferon Gamma

Gamma-Tocotrienol

Gamma hydroxybutyric

TC BioPharm

United Kingdom

Acurx Pharmaceuticals

United States

LAVA Therapeutics

Netherlands

Stealth BioTherapeutics Appoints David A. Brown as Chief Scientific Officer to Advance Mitochondrial Medicine Pipeline

Stealth BioTherapeutics Advances First FDA-Approved Mitochondrial Therapy FORZINITY for Barth Syndrome

Stealth BioTherapeutics Reports Strong Early Uptake for FORZINITY in Barth Syndrome Treatment